Loading...
7 Rare Disease Drugs Reports
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Amgen, Biomarin Pharmaceutical, Bayer, Bristol-Myers Squibb, AstraZeneca
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Takeda Pharmaceuticals, Novartis, Johnson & Johnson, Roche, Bristol-Myers Squibb
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Bavarian Nordic, SIGA Technologies, Chimerix
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Boehringer Ingelheim, Celgene, arGentis Pharmaceuticals Llc, Kadmon Holdings, Emerald Health Pharmaceuticals
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: CSL Behring, Takeda Pharmaceuticals, Grifols, Kedrion Biopharma, Octapharma
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific
Major Players: Roche, TG Therapeutics, Opexa Therapeutics, Mitsubishi Tanabe Pharma, Horizon Therapeutics
Study Period: 2021 - 2030
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: CSL Behring, Merz Pharma, Kedrion Biopharma, US WorldMeds, Aquestive Therapeutics
Filter Reports
By Region
By Countries